You have a say in how your pain is treated
Everyone experiences pain differently. For patients having an oral surgical procedure, there are unique factors that can affect recovery and how pain is managed after surgery. Pain management for surgery may include different combinations of treatments, including opioid and non-opioid options. Talk to the doctor about a pain management plan that is right for you or your family member having surgery. Create your discussion guide now.
EXPAREL is an opioid-free option to help control pain after surgery. EXPAREL may be used with other pain medications prescribed by your surgeon. Learn more.
Oral (mouth) or maxillofacial (face and jaw) surgery covers many types of procedures, including
- Wisdom tooth removal
- Temporomandibular joint (TMJ) surgery
- Reconstructive or corrective surgery
- Facial plastic surgery
Many patients receive opioids after surgery, but opioids aren’t for everyone
SIDE EFFECTS from opioids can slow down your recovery
- Opioids may cause nausea, vomiting, and constipation
- Opioids may make you feel drowsy or confused
Young adults who take opioids after oral surgery are 3 times more likely to become long-term users
100 million opioids go unused by patients every year—these pills can be misused and abused by others
While many patients may receive opioids after surgery, there are other options that can help you during recovery. That’s why it’s important to discuss these options with your doctor.
Ask your doctor about the opioid-free option―EXPAREL for long-lasting pain relief after surgery
- EXPAREL starts controlling pain during surgery and continues for the first few days after surgery, when you need it the most
- It works by numbing the area of your body where your surgery was performed, unlike opioids, which affect your whole body
In wisdom tooth removal surgeries, patients given EXPAREL*
Reported less pain
Required fewer opioids†
*Based on clinical studies of surgeries using EXPAREL as an alternative to standard of care.
†The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials.